87 related articles for article (PubMed ID: 12792775)
21. Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.
Halvorsen OJ; Oyan AM; Bø TH; Olsen S; Rostad K; Haukaas SA; Bakke AM; Marzolf B; Dimitrov K; Stordrange L; Lin B; Jonassen I; Hood L; Akslen LA; Kalland KH
Int J Oncol; 2005 Feb; 26(2):329-36. PubMed ID: 15645116
[TBL] [Abstract][Full Text] [Related]
22. Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application.
Ogawa K; Utsunomiya T; Mimori K; Yamashita K; Okamoto M; Tanaka F; Inoue H; Ikeda Y; Saku M; Murayama S; Mori M
Int J Oncol; 2005 Aug; 27(2):417-26. PubMed ID: 16010423
[TBL] [Abstract][Full Text] [Related]
23. Gene expression of colorectal cancer: preoperative genetic diagnosis using endoscopic biopsies.
Komori T; Takemasa I; Yamasaki M; Motoori M; Kato T; Kikkawa N; Kawaguchi N; Ikeda M; Yamamoto H; Sekimoto M; Matsubara K; Matsuura N; Monden M
Int J Oncol; 2008 Feb; 32(2):367-75. PubMed ID: 18202759
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
25. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
26. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
27. Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis.
Komuro K; Tada M; Tamoto E; Kawakami A; Matsunaga A; Teramoto K; Shindoh G; Takada M; Murakawa K; Kanai M; Kobayashi N; Fujiwara Y; Nishimura N; Hamada J; Ishizu A; Ikeda H; Kondo S; Katoh H; Moriuchi T; Yoshiki T
J Surg Res; 2005 Apr; 124(2):216-24. PubMed ID: 15820251
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer.
Gómez del Pulgar T; Bandrés E; Espina C; Valdés-Mora F; Pérez-Palacios R; García-Amigot F; García-Foncillas J; Lacal JC
Int J Biochem Cell Biol; 2007; 39(12):2289-302. PubMed ID: 17766170
[TBL] [Abstract][Full Text] [Related]
30. Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles.
Ochi K; Daigo Y; Katagiri T; Nagayama S; Tsunoda T; Myoui A; Naka N; Araki N; Kudawara I; Ieguchi M; Toyama Y; Toguchida J; Yoshikawa H; Nakamura Y
Int J Oncol; 2004 Mar; 24(3):647-55. PubMed ID: 14767549
[TBL] [Abstract][Full Text] [Related]
31. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of TROP2 expression in colorectal cancer.
Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M
Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
34. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
[TBL] [Abstract][Full Text] [Related]
35. Identification of gene signatures for invasive colorectal tumor cells.
Wiese AH; Auer J; Lassmann S; Nährig J; Rosenberg R; Höfler H; Rüger R; Werner M
Cancer Detect Prev; 2007; 31(4):282-95. PubMed ID: 17936523
[TBL] [Abstract][Full Text] [Related]
36. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
37. Identification of the molecular mechanisms for dedifferentiation at the invasion front of colorectal cancer by a gene expression analysis.
Oku Y; Shimoji T; Takifuji K; Hotta T; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Nasu T; Tamura K; Matsuura M; Miyata S; Kato Y; Yamaue H; Miki Y
Clin Cancer Res; 2008 Nov; 14(22):7215-22. PubMed ID: 19010838
[TBL] [Abstract][Full Text] [Related]
38. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms.
Zhang W; Hart J; McLeod HL; Wang HL
Am J Clin Pathol; 2005 Jul; 124(1):11-9. PubMed ID: 15923159
[TBL] [Abstract][Full Text] [Related]
40. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]